Immunotherapy for Merkel cell carcinoma -- novel research highlights quality of life benefits

(Future Science Group) Researchers have presented the association between tumor response and health-related quality of life in patients with metastatic Merkel cell carcinoma treated with avelumab.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news